Central banks' worst nightmare:  inflation and a new Covid strain Central banks' worst nightmare:  inflation and a new Covid strain Central banks' worst nightmare:  inflation and a new Covid strain

Central banks' worst nightmare: inflation and a new Covid strain

Althea Spinozzi

Senior Fixed Income Strategist

Summary:  There is plenty of reasons to remain cautious, especially in a day where thin liquidity might provide a distorting view on events. Yet, it's important to consider what a new wave of Covid means for markets now that central banks were set to enact less accommodative monetary policies. The Federal Reserve may remain hawkish as stimulating demand can produce stronger price pressures. However, if new restrictions and lockdowns are imposed, the market will need to cut back on growth expectations. Therefore, we cannot exclude an inversion of the yield curve.

This morning, the market was caught by surprise with the news of a new Covid variant coming from South Africa. Investors flew to safety in a typical “sell now, make questions later" fashion, pushing down bond yields, together with oil prices and the stock market.

The big question remains whether today’s flight to safety is justified or not. However, nobody can answer this question because there is too little information at hand. What we can do is to work with what we already know: central banks are concerned about inflation and are getting ready to tighten the economy. However, can they continue with their hawkish plans despite a new wave of infection that might cause countries to impose restrictions and lockdowns? The short answer to that question is yes. They will need to because a lockdown can further exacerbate inflationary pressures by worsening supply-chain bottlenecks. Easing the demand looks like the most sensible thing to do not to overheat the economy further.

Yet, in a day where liquidity is so thin, one has to be careful to overreact with what the market is “saying”. That’s why we believe that the deep drop of yields, especially in the belly of the curve, might be overdone, especially under the prospect that the Federal Reserve will accelerate the pace of tapering in December. At the same time, the market pushed back on interest rate hikes expectations. While yesterday it was expecting almost three hikes in 2022, today it is pricing only two. Yet, provided that a new wave of Covid will be temporary, it’s safe to assume that rate hikes will accelerate once that market sentiment normalizes.

Therefore, the front part of the yield curve might soon resume its rise. However,  there is a chance that long-term yields will stabilize or even fall amid growth concerns. Hence, we are heading toward the risk to see the yield curve inverting.

The spread between 30-years and 5-year US Treasuries is well below 100bps. However, the spread between 30-year yields and 10-year yields it's even tighter -just 36bps. The spread between 10-years and the 7-years yields it's just 8bps. It means that we are not far off from an inversion scenario, which is often seen as a solid recessionary predictor.

There is plenty of reasons to remain cautious, especially in a day where thin liquidity might provide a distorting view on events. Next week, we will gain a better picture when the American market has digested the Thanksgiving turkey and liquidity is restored.

Source: Bloomberg and Saxo Group.

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.